Welcome to the international HTA database

Showing [21959 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: treatment of mitral regurgitation by a percutaneous device with clip (TMVRc)]
2019	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Stereotactic neurosurgery frameless. The iSYS1® Robotic device]
2019	Norwegian Institute of Public Health (NIPH)	Disease modifying treatments for relapsing remitting multiple sclerosis. A health economic evaluation
2019	Norwegian Institute of Public Health (NIPH)	Disease-modifying treatments for relapsing remitting multiple sclerosis, including rituximab. A health technology assessment
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ external condylomas (anogenital warts)]
2019	Andalusian Health Technology Assessment Area (AETSA)	PET usefulness in non-oncological indications
2019	Norwegian Institute of Public Health (NIPH)	Prehospital CT for early diagnosis and treatment of suspected acute stroke or severe head injury
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: best strategies for reducing the risk of severe toxicities caused by dihydropyrimidine dehydrogenase deficiency]
2019	Haute Autorite de sante (HAS)	[Assessment of pulp wound protection by direct pulp capping]
2019	Andalusian Health Technology Assessment Area (AETSA)	Clinical Utility of Procalcitonin–Guidance for initiation of antimicrobian treatment in patients admitted to the ICU
2019	Norwegian Institute of Public Health (NIPH)	Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer. Assessment of manufacturer’s submission
2019	Norwegian Institute of Public Health (NIPH)	Health technology assessment of Transcatether aortic valve implantation (TAVI) as treatment of patients with severe aortic stenosis and intermediate surgical risk – Part 2. Health economic evaluation
2019	NIHR Health Technology Assessment programme	Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2019	Norwegian Institute of Public Health (NIPH)	Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Canagliflozin, empagliflozin and dapagliflozin in type 2 diabetes patients]
2019	Norwegian Institute of Public Health (NIPH)	Hyperbaric oxygen therapy for osteonecrosis
2019	NIHR Public Health Research (PHR) programme	Mass media to communicate public health messages in six health topic areas: a systematic review and other reviews of the evidence
2019	NIHR Health Technology Assessment programme	Trial of Acute Femoral Fracture Fixation (TrAFFix). A feasibility study
2019	Finnish Coordinating Center for Health Technology Assessment (FinCCHTA)	[Surgical smoke during operations - the risks to personnel, and the protective measures needed]
2019	Adelaide Health Technology Assessment (AHTA)	Alpha Thalassaemia genetic testing
2019	NIHR Health Technology Assessment programme	Developing and evaluating a tool to measure general practice productivity: a multimethod study
2019	NIHR Health Technology Assessment programme	Developing a reporting guideline to improve meta-ethnography in health research: the eMERGe mixed-methods study
2019	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Axicabtagene ciloleucel (PMBCL)]
2019	Swiss Federal Office of Public Health (FOPH)	Removal of osteosynthesis materials (e.g. screws, plates, nails and wires) used to treat bone fractures
2019	NIHR Health Technology Assessment programme	An intervention to improve outcomes of falls in dementia: the DIFRID mixed-methods feasibility study
2019	Swiss Federal Office of Public Health (FOPH)	Self-measurement of blood glucose in patients with non-insulin treated diabetes mellitus type 2
2019	NIHR Health Services and Delivery Research programme	Innovation to enhance health in care homes: rapid evidence synthesis
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Bevacizumab in age-related macular degeneration]
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Thiazolidinediones for type 2 diabetes mellitus]
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Canagliflozin, empagliflozin and dapagliflozin (SGLT-2) for patients with type 2 diabetes]
2019	NIHR Health Technology Assessment programme	A peer-led physical activity intervention in schools for adolescent girls: a feasibility RCT
2019	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Transmural fixation of aortic endograft adjunct to endovascular aneurysm repair using helical anchors
2019	Andalusian Health Technology Assessment Area (AETSA)	[Blood test for the early diagnosis of pancreatic cancer. CancerSEEK]
2019	NIHR Health Technology Assessment programme	MRI in the diagnosis of fetal developmental brain abnormalities: the MERIDIAN diagnostic accuracy study
2019	Andalusian Health Technology Assessment Area (AETSA)	[Post-introduction observational study of predictive/prognostic tests in breast cancer of the Andalusian Public Health System (SSPA)]
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Pirfenidone in pulmonary fibrosis]
2019	NIHR Health Technology Assessment programme	Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the ANODE RCT
2019	NIHR Health Services and Delivery Research programme	Improving NHS quality using internet ratings and experiences (INQUIRE)
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Hyaluronic acid dermal fillers in skin repair procedures]
2019	Agency for Healthcare Research and Quality (AHRQ)	Achieving health equity in preventive services
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Alirocumab for patients with hypercholesterolemia]
2019	NIHR Health Technology Assessment programme	Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[PET-CT in patients with head and neck cancer diagnosis]
2019	Agency for Healthcare Research and Quality (AHRQ)	Addressing social isolation to improve the health of older adults: a rapid review
2019	NIHR Health Technology Assessment programme	Anal fistula plug versus surgeon's preference for surgery for trans-sphincteric anal fistula: the FIAT RCT
2019	NIHR Health Services and Delivery Research programme	Evaluation of specialist nursing support for carers of people with dementia
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Relex® SMILE® surgery for refractive errors]
2019	Agency for Healthcare Research and Quality (AHRQ)	Adverse effects of pharmacological treatments of major depression in older adults
2019	NIHR Health Services and Delivery Research programme	Understanding and enhancing how hospital staff learn from and act on patient experience data
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Liraglutide in obese and overweight patients]
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Respiratory polygraphy for obstructive sleep apnea syndrome]
2019	Agency for Healthcare Research and Quality (AHRQ)	Antipsychotics for the prevention and treatment of delirium
2019	NIHR Health Services and Delivery Research programme	A study of sense-making strategies and help-seeking behaviours associated with the use and provision of urgent care services
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Thiazolidinediones for type 2 diabetes mellitus]
2019	NIHR Health Technology Assessment programme	Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study
2019	NIHR Health Technology Assessment programme	Refusal and resistance to care by people living with dementia being cared for within acute hospital wards: an ethnographic study
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Positron-emission tomography for breast cancer]
2019	The Regional Health Technology Assessment Centre (HTA-centrum)	Efficacy of sleep deprivation in patients with depression including bipolar depression
2019	NIHR Health Technology Assessment programme	A school-based intervention ('Girls Active') to increase physical activity levels among 11- to 14-year-old girls: cluster RCT
2019	Penn Medicine Center for Evidence-based Practice (CEP)	The Effect of Patient Communication About Medical Errors on Malpractice Lawsuits
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Intra-articular hyaluronic acid (viscosupplementation) for osteoarthritis]
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Interventions to Reduce the Use of the High Risk Medications in Elderly Patients
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Kinanthropometric nutritional assessment]
2019	The Regional Health Technology Assessment Centre (HTA-centrum)	Gene expression profiles to guide adjuvant chemotherapy in luminal, HER2-negative breast cancer
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Guidelines for Supplementary Feedings of Newborn Infants
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[High frequency chest compression vest for ambulatory pulmonary physical therapy in patients with cystic fibrosis]
2019	The Regional Health Technology Assessment Centre (HTA-centrum)	Impact of postmastectomy radiotherapy on complications and results of immediate breast reconstruction
2019	NIHR Health Technology Assessment programme	Developing an intervention around referral and admissions to intensive care: a mixed-methods study
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Bioresorbable stents for the treatment of cardiovascular indications (coronary artery disease). EUnetHTA-Report
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Cerliponase alfa in neuronal ceroid lipofuscinosis type 2]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Lenvatinib (hepatocellular carcinoma) - Benefit assessment according to §35a Social Code Book V]
2019	The Regional Health Technology Assessment Centre (HTA-centrum)	EEG-based neurofeedback as treatment for post-traumatic stress disorder
2019	NIHR Health Technology Assessment programme	Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Olaparib (Lynparza®) as first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer
2019	The Regional Health Technology Assessment Centre (HTA-centrum)	Trabecular bone pattern assessment in dental radiographs for prediction of bone fracture risk
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Atezolizumab (Tecentriq®) with nab-paclitaxel (Abraxane®) for the treatment of advanced triple-negative breast cancer (aTNBC)
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Prolotherapy in chronic musculoskeletal disorders]
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections. EUnetHTA-Report
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Percutaneous cement discoplasty for the treatment of degenerative scoliosis in the elderly]
2019	NIHR Health Technology Assessment programme	Treatment of first-time traumatic anterior shoulder dislocation UK.TASH-D Study
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Evaluation methods for the benefit assessment of easily accessible, outpatient health centres for vulnerable groups - Target group focus: Homeless and non-insured persons
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Shear-wave elastography for liver fibrosis]
2019	Agency for Healthcare Research and Quality (AHRQ)	Comparative effectiveness of analgesics to reduce acute pain in the prehospital setting
2019	NIHR Health Services and Delivery Research programme	The changing general practitioner workforce: the development of policies and strategies aimed at retaining experienced GPs and those taking a career break in direct patient care (ReGROUP)
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Robot-assisted surgery in thoracic and visceral indications
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: Alphanate - von Willebrand disease]
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Bendamustine as first line therapy for indolent non-Hodgkin’s lymphoma]
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Darolutamide for the treatment of patients with nonmetastatic castration-resistant prostate cancer (CRPC)
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Erenumab in migraine prevention]
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Annulus Fibrosus Repair after lumbar discectomy
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[4CMenB vaccine for primary vaccination]
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Single/two-step scaffold-based cartilage repair in the knee and ankle joint
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Teriparatide in biphosphonate-resistant osteoporosis and high fracture risk]
2019	Agency for Care Effectiveness (ACE)	Video capsule endoscopy for diagnosing obscure gastrointestinal bleeding
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Radiofrequency denervation for lumbar and cervical facet joint pain – a systematic review
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Immunocyanin in urothelial bladder cancer
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Upper Airway Stimulation for Moderate-to-Severe Sleep Apnea. 1st Update 2019
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Central auditory processing disorder diagnosis]